Companies
BDI BioLife
- Country
- Austria
Commercial
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| aquaculture-seafood | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | No funding raised | prospeo.io |
| Capacity | Up to 15 metric tons of algae biomass per year | projekte.ffg.at |
| Certification | Halal, ISO 9001, FSSC 22000, COSMOS, Kosher, and Natrue approval | ingredientsnetwork.com |
| Regulatory approval | GRAS (Generally Recognized as Safe) status from the US FDA | bdi-biolifescience.com |
| Production site | Am Ökopark 22, 8230 Hartberg, Austria | bdi-biolifescience.com |
| Headcount | 15 employees (2024) | firmenakte.at |
| Revenue | 1.4 million EUR annual surplus (2024) | firmenatlas.com |
Independent sources: firmenakte.at · firmenatlas.com · ingredientsnetwork.com · projekte.ffg.at · prospeo.io
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Microalgal carotenoids | aquaculture-seafood | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.